The retina specialists of Southeastern Retina Associates place a high priority on our commitment to the advancement of medical research. Our physicians continue to be in the forefront with their clinical research participation and in the development of major innovations in retina care.
Southeastern Retina Associates is proud of its participation in research studies demonstrating the highest professional standards and exemplary clinical practice. SERA physicians have been leading clinical trials for more than 20 years! Patient participation in trials is voluntary, and has allowed the latest treatments to become available to all patients who need treatment for advanced eye diseases.
Southeastern Retina participates in several clinical trials that are investigating new forms of treatment for macular degeneration, diabetic retinopathy, and a variety of other retinal conditions.
Below, are descriptions of clinical trials in which we are currently participating or have recently participated at Southeastern Retina Associates’ three East Tennessee main locations. More information on clinical trials is available at clinicaltrials.gov.
CURRENTLY ENROLLING CLINICAL TRIALS
|Diabetic Macular Edema||GLIMMER||Knoxville||Yes|
|Diabetic Retinopathy (NPDR)||PAVILION||Knoxville||Yes|
|Diabetic Retinopathy (NPDR)||DRCR AF||Knoxville||Yes|
|Macular Telangiectasia Type II||NHOR||Knoxville||Yes|
|Retinal Vein Occlusion||BEACON||Knoxville||Yes|
ONGOING / NOT ENROLLING TRIALS
|Diabetic Macular Edema||RHINE||Chattanooga||No|
|Diabetic Macular Edema||KINGFISHER||Chattanooga||No|
|Diabetic Macular Edema||RHONE-X||Chattanooga||No|
|Diabetic Macular Edema||PHOTON||Knoxville / Chattanooga||No|
|Diabetic Retinopathy||DRCR-W||Knoxville / Chattanooga||No|
|Macular Telangiectasia Type II||NTMT-03-A||Knoxville||No|
|Wet Macular Degeneration||KSI-CL-102||Knoxville||No|
|Wet Macular Degeneration||LUCERNE||Chattanooga||No|
|Geographic Atrophy||GATHER2||Knoxville / Tri-Cities||No|
To ask about trials currently enrolling and the requirements to take part, patients or referring physicians may call any of SERA’s Clinical Trials Coordinators listed below.
Steve McBee: 423-756-1002
Kristina Oliver: 865-588-0811
Sarah Oelrich: 423-578-4364